“Pharmacogenomic Profiling in Personalized Therapeutics: Predicting Drug Response in High-Risk Patients With Cardiometabolic Disorders”. 2025. International Journal of Health and Medical Research 1 (01): 28-37. https://research-education.com/index.php/ijhmr/article/view/6.